Atlas Trials

An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)

Clinical trial NCT05765578 · COMPLETED

Trial details

NCT number
NCT05765578
Sponsor
ModernaTX, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19
Start date
2023-03-08
Primary completion
2024-06-17
Enrollment
1713

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.